MeSH D003550 - cystic fibrosis
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Teva | Hydrochlorothiazide, Amiloride | Amiloride Hydrochlorothiazide |  | 1988-04-17 |  |  |
| Colistimethate | Colobreathe |  | 2012-02-13 |  |  | |
| Padagis | Amiloride | Midamor |  | 1982-01-01 |  |  |
| Merck Sharp & Dohme | Hydrochlorothiazide, Amiloride | Moduretic |  | 1982-01-01 |  |  |
| Barr Pharmaceuticals | Hydrochlorothiazide, Amiloride | Amiloride Hydrochlorothiazide |  | 1988-05-10 |  |  |
| Rising Pharmaceuticals | Acetylcysteine | Acetylcysteine |  | 2015-03-24 |  |  |
| Hydrochlorothiazide, Amiloride | Amiloride Hydrochlorothiazide |  | 1991-10-31 |  |  | |
| Zydus Therapeutics | Acetylcysteine | Acetylcysteine |  | 2018-07-20 |  |  |
| Hospira | Acetylcysteine | Acetylcysteine |  | 1989-05-01 |  |  |
| Arbor Pharmaceuticals | Acetylcysteine | Cetylev | 2032-05-08 | 2016-01-29 |  |  |
| Chartwell Pharmaceuticals | Amiloride | Amiloride |  | 2015-08-07 |  |  |
| Hydrochlorothiazide, Amiloride | Amiloride Hydrochlorothiazide |  | 1991-11-27 |  |  | |
| Bristol Myers Squibb | Acetylcysteine | Mucomyst |  | 1982-01-01 |  |  |
1
2
3
4
>
Clinical Trials
Historical Success Rate
Phase 1
65%39/60
Phase 2
44%40/91
Phase 3
68%40/59
Approved: 16Overall Success rate: 19%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
3
>
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use